Dr. Jennifer Morris Grossman, MD

Dr. Grossman practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Grossman's NPI, 1548289820, was assigned on July 18, 2006. Dr. Grossman graduated from University of Rochester Medical Center in 1993. Dr. Grossman's California license number on file is G81407.

Dr. Grossman's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Grossman's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Grossman is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Grossman to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grossman practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Grossman's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Grossman is board certified in rheumatology by the American Board of Internal Medicine. Dr. Grossman has a license on file in California.

Dmand AI lists arteritis, arthritis, fluid in a joint, joint pain, lupus, muscle pain, fibromyalgia, and limb pain, osteoporosis and rheumatoid arthritis among the conditions Dr. Grossman treats.

CMS data shows 637 Medicare services from Dr. Grossman across 3 procedure codes in 2024, for 168 Medicare patients. Medicare paid $30,097 for them.

CMS counts 168 Medicare patients who saw Dr. Grossman in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have arthritis, and 71% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Grossman's median patient age at 54, with 81% women.

In 2024, Dr. Grossman wrote 1,363 Medicare Part D claims for 191 patients. 85% of them were for generic drugs. CMS names the drug for 957 of them, across 34 drugs with 11 or more claims each, at $764,685 in total drug cost. In 2023, CMS named 1,041 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Grossman for performance year 2024, reported as part of a group. Dr. Grossman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Grossman as offering telehealth.

Dmand AI links 5 papers to Dr. Grossman, published from 2011 to 2017. Dr. Grossman's most frequent co-authors are Bevra Hannahs Hahn, MD, Gary S. Gilkeson, MD and Christina Marie Charles-Schoeman, MD.

Dmand AI links Dr. Grossman to 1 clinical trial. Conditions studied include Lupus Erythematosus, Systemic and Connective Tissue Diseases. Open Payments lists research payments to Dr. Grossman that name 1 trial.

CMS Open Payments shows 11 general payments to Dr. Grossman from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 96% of the total. Novartis Pharmaceuticals Corporation paid the most, $128. It also lists 1 research payment totaling $818 in 2019, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Grossman, most recently CMS Stage 1 EHR in 2013.

Dr. Grossman graduated from University of Rochester Medical Center in 1993. Dr. Grossman is a member of ACR.

Dr. Grossman is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.